Gene: ENTR1
Official Full Name: endosome associated trafficking regulator 1provided by HGNC
Gene Summary: Involved in several processes, including endocytic recycling; positive regulation of cilium assembly; and positive regulation of protein localization to cilium. Located in several cellular components, including endosome; microtubule organizing center; and retromer complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31492 | ENTR1 Knockout cell line (HeLa) | Human | ENTR1 | 1:3~1:6 | Negative | Online Inquiry |
KO31493 | ENTR1 Knockout cell line (HCT 116) | Human | ENTR1 | 1:2~1:4 | Negative | Online Inquiry |
KO31494 | ENTR1 Knockout cell line (HEK293) | Human | ENTR1 | 1:3~1:6 | Negative | Online Inquiry |
KO31495 | ENTR1 Knockout cell line (A549) | Human | ENTR1 | 1:3~1:4 | Negative | Online Inquiry |
ENTR1 Gene Knockout Cell Lines are a specialized selection of engineered cells where the ENTR1 gene has been precisely disrupted, enabling researchers to study the gene's function and its impact on various biological processes. These cell lines are generated using advanced CRISPR-Cas9 technology, ensuring a high efficiency of gene editing while minimizing off-target effects. By providing a robust model for examining ENTR1 gene functions, these cell lines facilitate an in-depth understanding of both normal cellular physiology and pathological conditions linked to ENTR1 deregulation.
The key functions of the ENTR1 gene are closely tied to cellular signaling pathways and transport mechanisms, which play a crucial role in nutrient uptake and drug resistance. Researchers can utilize ENTR1 Knockout Cell Lines to dissect the gene's involvement in these processes, allowing for insights that could lead to novel therapeutic targets, particularly in the treatment of metabolic disorders and cancer. The products have significant applications in basic research, pharmacology, and drug development, making them invaluable tools in the quest for new medical interventions.
What sets our ENTR1 Gene Knockout Cell Lines apart from alternative products is their rigorously validated performance in both in vitro and in vivo settings. We ensure that each cell line comes with characterization data and functional assays that attest to its specificity and reproducibility, thereby offering a reliable platform for experimental reproducibility.
For researchers and clinicians focused on deciphering the complexities of gene function and disease mechanisms, these cell lines provide a valuable, ready-to-use tool that can accelerate experimental timelines and enhance research quality.
Our company, a leader in the field of gene editing and cellular biology, combines years of expertise with a commitment to advancing scientific discovery. Our product offerings, rooted in the latest biotechnological advancements, empower researchers to push boundaries and achieve breakthroughs that improve health outcomes worldwide.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.